← Back to S&P 500 Dashboard

BAX

INSUFFICIENT DATA

Baxter International Inc.

Healthcare · Rank #496 · Analyzed Apr 20, 2026

$18.71

Current Price

$9.46

Intrinsic Value

-49.5%

Upside/Downside

0/10

Score

1/5

Quality

Analysis Summary

Valuation Consensus0/1 methods agree
Quality Score1/5.0
Framework RatingINSUFFICIENT DATA
Price vs Intrinsic ValueOvervalued by 49.5%

Fair Value Range

Low$9.46
Base (IV)$9.46
High$9.46

Entry Points

Conservative$9.46
Moderate$9.46
Aggressive$9.46

⚠️ Warnings

  • DCF discarded: negative profit margins
  • Insufficient data: fewer than 2 valuation methods

Quality & Moat Breakdown

Return on Equity-13.7% → 0/1.0
Debt LevelD/E 160 → 0/1.0
Revenue QualityGrowth 18.2%, margin Δ-16.9% +recovery → 1.0/1.0
Moat Strength1.5/5 → 0/1.0
Profit Margins-8.5% → 0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.